FORM OF INDEMNITY AGREEMENTIndemnity Agreement • March 10th, 2021 • XOMA Corp • Pharmaceutical preparations • California
This Indemnity Agreement (this “Agreement”) dated as of _______________, 20__, is made by and between XOMA Corporation, a Delaware corporation (the “Company”), and ______________________ (“Indemnitee”).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • March 10th, 2021 • XOMA Corp • Pharmaceutical preparations • California
This Non-exclusive License Agreement (the “Agreement”), effective as of November 30, 2001 (the “Effective Date”), is entered into by and between XOMA Ireland Limited (“XOMA”), an Irish company having offices located at Shannon Airport House, Shannon, County Clare, Ireland, and Viventia Biotech Inc. (“VIVENTIA”), a Canadian corporation having offices located at 10 Four Seasons Place, Suite 510, Toronto, Ontario, Canada M9B 6H7.
AMENDMENT NO. 1 TO COMMON STOCK SALES AGREEMENT Common Stock Sales Agreement • March 10th, 2021 • XOMA Corp • Pharmaceutical preparations • New York
XOMA Corporation, a Delaware corporation (the “Company”), together with H.C. Wainwright & Co., Inc. (the “Agent”), are parties to that certain Common Stock Sales Agreement dated December 18, 2018 (the “Original Agreement”). All capitalized terms not defined herein shall have the meanings ascribed to them in the Original Agreement. The Company and the Agent desire to amend the Original Agreement as set forth in this Amendment No. 1 thereto (this “Amendment) as follows (to be effective as set forth in paragraph 5 below):
